151.65
+0.65
+(0.43%)
At close: April 16 at 4:59:39 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
1,949,832
1,949,832
1,119,206
220,053
-358,500
Investing Cash Flow
-1,870,863
-1,870,863
-945,564
-877,405
-2,876,946
Financing Cash Flow
55,775
55,775
735,832
635,820
3,536,080
End Cash Position
1,623,490
1,623,490
1,477,234
575,407
591,820
Capital Expenditure
-1,687,637
-1,687,637
-977,405
-1,381,575
-1,058,451
Issuance of Capital Stock
126,794
126,794
1,687,430
37,918
2,963,779
Issuance of Debt
--
--
240,000
1,003,661
660,000
Repayment of Debt
-1,921
-1,921
-1,105,545
-374,339
-2,173
Repurchase of Capital Stock
-27,459
-27,459
-8,988
-9,328
-8,581
Free Cash Flow
262,195
262,195
141,801
-1,161,522
-1,416,951
12/31/2021 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GMAB.CO Genmab A/S
1,291.50
-0.12%
ZEAL.CO Zealand Pharma A/S
424.50
-4.61%
ALK-B.CO ALK-Abelló A/S
148.60
+1.36%
GUBRA.CO Gubra A/S
356.00
-4.30%
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
18.98
-2.16%
HNSA.ST Hansa Biopharma AB (publ)
21.98
+2.14%
GMAB Genmab A/S
20.04
+2.51%
EVAX Evaxion Biotech A/S
1.3090
+1.47%
SANION.ST Saniona AB (publ)
6.40
+4.07%
PILA.ST Pila Pharma AB (publ)
3.4650
-0.14%